Bevacizumab (216974-75-3) ≥98%
Koffersyrafenetylester (CAPE) ≥98%
Dolastatin 10 (110417-88-4) ≥98%
Fosaprepitant dimeglumin (EMEND) ≥98%
MMAD (Demethyldolastatin 10) ≥98%
MMAF (hydroklorid) (1415246-68-2) ≥98%
Monometyl-auristatin E (MMAE) ≥98%
N-Boc-dolaproin (120205-50-7) ≥98%
Pyridoxal-5-fosfat Monohydrat ≥98%
3-Methoxy-13-ethyl-gona-2,5 (10)-diene-17-ol ≥98%
N-phenyl-4-(3-phenyl-1,2,4-thiadiazol-5-yl)piperazine-1-carboxamide ≥98%